LabCentral, the biotech incubator in Cambridge, Mass., that has nurtured dozens of startups in a shared working space since 2013, plans to roughly double in size in two years with a new 100,000-square-foot facility in the heart of Kendall Square.
But instead of providing laboratory equipment for scientists to do early-stage research, the new outpost will help startups that have cleared that hurdle to develop potential drugs that the firms eventually hope to test in clinical trials.
